Absence of Common Somatic Alterations in Genes on 1p and 19q in Oligodendrogliomas

被引:9
作者
Bralten, Linda B. [1 ]
Nouwens, Stephan [2 ]
Kockx, Christel [3 ]
Erdem, Lale [1 ]
Hoogenraad, Casper C. [4 ]
Kros, Johan M. [5 ]
Moorhouse, Michael J. [2 ]
Smitt, Peter A. Sillevis [1 ]
van der Spek, Peter [2 ]
van Ijcken, Wilfred [3 ]
Stubbs, Andrew [2 ]
French, Pim J. [1 ]
机构
[1] Erasmus MC, Dept Neurol, Rotterdam, Netherlands
[2] Erasmus MC, Dept Bioinformat, Rotterdam, Netherlands
[3] Erasmus MC, Ctr Biom, Rotterdam, Netherlands
[4] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands
[5] Erasmus MC, Dept Pathol, Rotterdam, Netherlands
来源
PLOS ONE | 2011年 / 6卷 / 07期
关键词
CANDIDATE TUMOR-SUPPRESSOR; CANCER; MUTATIONS; IDH1; IDENTIFICATION; RESTORATION; SURVIVAL; REGION; GLIOMA; 10Q;
D O I
10.1371/journal.pone.0022000
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A common and histologically well defined subtype of glioma are the oligodendroglial brain tumors. Approximately 70% of all oligodendrogliomas have a combined loss of the entire 1p and 19q chromosomal arms. This remarkably high frequency suggests that the remaining arms harbor yet to be identified tumor suppressor genes. Identification of these causal genetic changes in oligodendrogliomas is important because they form direct targets for treatment. In this study we therefore performed targeted resequencing of all exons, microRNAs, splice sites and promoter regions residing on 1p and 19q on 7 oligodendrogliomas and 4 matched controls. Only one missense mutation was identified in a single sample in the ARHGEF16 gene. This mutation lies within-and disrupts the conserved PDZ binding domain. No similar ARHGEF16 mutations or deletions were found in a larger set of oligodendrogliomas. The absence of common somatic changes within genes located on 1p and 19q in three out of four samples indicates that no additional "second hit'' is required to drive oncogenic transformation on either chromosomal arm.
引用
收藏
页数:6
相关论文
共 37 条
[1]   EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma [J].
Alaminos, M ;
Dávalos, V ;
Ropero, S ;
Setién, F ;
Paz, MF ;
Herranz, M ;
Fraga, MF ;
Mora, J ;
Cheung, NKV ;
Gerald, WL ;
Esteller, M .
CANCER RESEARCH, 2005, 65 (07) :2565-2571
[2]   The quest for the 1p36 tumor suppressor [J].
Bagchi, Anindya ;
Mills, Alea A. .
CANCER RESEARCH, 2008, 68 (08) :2551-2556
[3]   CHD5 is a tumor suppressor at human 1p36 [J].
Bagchi, Anindya ;
Papazoglu, Cristian ;
Wu, Ying ;
Capurso, Daniel ;
Brodt, Michael ;
Francis, Dailia ;
Bredel, Markus ;
Vogel, Hannes ;
Mills, Alea A. .
CELL, 2007, 128 (03) :459-475
[4]  
Barbashina V, 2005, CLIN CANCER RES, V11, P1119
[5]   IDH1 R132H Decreases Proliferation of Glioma Cell Lines In Vitro and In Vivo [J].
Bralten, Linda B. C. ;
Kloosterhof, Nanne K. ;
Balvers, Rutger ;
Sacchetti, Andrea ;
Lapre, Lariesa ;
Lamfers, Martine ;
Leenstra, Sieger ;
de Jonge, Hugo ;
Kros, Johan M. ;
Jansen, Erwin E. W. ;
Struys, Eduard A. ;
Jakobs, Cornelis ;
Salomons, Gajja S. ;
Diks, Sander H. ;
Peppelenbosch, Maikel ;
Kremer, Andreas ;
Hoogenraad, Casper C. ;
Smitt, Peter A. E. Sillevis ;
French, Pim J. .
ANNALS OF NEUROLOGY, 2011, 69 (03) :455-463
[6]   Integrated Genomic Profiling Identifies Candidate Genes Implicated in Glioma-Genesis and a Novel LEO1-SLC12A1 Fusion Gene [J].
Bralten, Linda B. C. ;
Kloosterhof, Nanne K. ;
Gravendeel, Lonneke A. M. ;
Sacchetti, Andrea ;
Duijm, Elza J. ;
Kros, Johan M. ;
van den Bent, Martin J. ;
Hoogenraad, Casper C. ;
Smitt, Peter A. E. Sillevis ;
French, Pim J. .
GENES CHROMOSOMES & CANCER, 2010, 49 (06) :509-517
[7]   Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas [J].
Broderick, DK ;
Di, CH ;
Parrett, TJ ;
Samuels, YR ;
Cummins, JM ;
McLendon, RE ;
Fults, DW ;
Velculescu, VE ;
Bigner, DD ;
Yan, H .
CANCER RESEARCH, 2004, 64 (15) :5048-5050
[8]   Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound [J].
Bykov, VJN ;
Issaeva, N ;
Shilov, A ;
Hultcrantz, M ;
Pugacheva, E ;
Chumakov, P ;
Bergman, J ;
Wiman, KG ;
Selivanova, G .
NATURE MEDICINE, 2002, 8 (03) :282-288
[9]   Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas [J].
Cairncross, JG ;
Ueki, K ;
Zlatescu, MC ;
Lisle, DK ;
Finkelstein, DM ;
Hammond, RR ;
Silver, JS ;
Stark, PC ;
Macdonald, DR ;
Ino, Y ;
Ramsay, DA ;
Louis, DN .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (19) :1473-1479
[10]   Comprehensive genomic characterization defines human glioblastoma genes and core pathways [J].
Chin, L. ;
Meyerson, M. ;
Aldape, K. ;
Bigner, D. ;
Mikkelsen, T. ;
VandenBerg, S. ;
Kahn, A. ;
Penny, R. ;
Ferguson, M. L. ;
Gerhard, D. S. ;
Getz, G. ;
Brennan, C. ;
Taylor, B. S. ;
Winckler, W. ;
Park, P. ;
Ladanyi, M. ;
Hoadley, K. A. ;
Verhaak, R. G. W. ;
Hayes, D. N. ;
Spellman, Paul T. ;
Absher, D. ;
Weir, B. A. ;
Ding, L. ;
Wheeler, D. ;
Lawrence, M. S. ;
Cibulskis, K. ;
Mardis, E. ;
Zhang, Jinghui ;
Wilson, R. K. ;
Donehower, L. ;
Wheeler, D. A. ;
Purdom, E. ;
Wallis, J. ;
Laird, P. W. ;
Herman, J. G. ;
Schuebel, K. E. ;
Weisenberger, D. J. ;
Baylin, S. B. ;
Schultz, N. ;
Yao, Jun ;
Wiedemeyer, R. ;
Weinstein, J. ;
Sander, C. ;
Gibbs, R. A. ;
Gray, J. ;
Kucherlapati, R. ;
Lander, E. S. ;
Myers, R. M. ;
Perou, C. M. ;
McLendon, Roger .
NATURE, 2008, 455 (7216) :1061-1068